U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
137221137221Elucidation and Monitoring Postprandial Endothelial FunctionCompletedNo Results AvailableCardiovascular Disease|Endothelial DysfunctionDietary Supplement: high fat meal|Dietary Supplement: control mealhttps://ClinicalTrials.gov/show/NCT00766623
137222137222Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected Antiretroviral Treatment Experienced Children and AdolescentsCompletedNo Results AvailableHIV InfectionsDrug: Vicrivirochttps://ClinicalTrials.gov/show/NCT00766597
137223137223Autonomic Nervous System Activity, Aging and Sleep Apnea/HypopneaActive, not recruitingNo Results AvailableHealthyOther: Sleep apnea/hypopnea detectionhttps://ClinicalTrials.gov/show/NCT00766584
137224137224Clinical and Genetic Studies of VACTERL AssociationRecruitingNo Results AvailableCongenital Abnormalities|Birth Defects|Congenital Defectshttps://ClinicalTrials.gov/show/NCT00766571
137225137225The Effects of Written Emotional Disclosure on Eating Disorder Pathology in a Clinical Eating Disordered PopulationNot yet recruitingNo Results AvailableAnorexia Nervosa|Bulimia Nervosa|Eating Disorderhttps://ClinicalTrials.gov/show/NCT00766558
137226137226Cilostazol Stroke Prevention Study : A Placebo-Controlled Double-Blind Trial for Secondary Prevention of Cerebral Infarction.CompletedNo Results AvailableCerebral InfarctionDrug: cilostazol|Drug: placebo of cilostazolhttps://ClinicalTrials.gov/show/NCT00766545
137227137227Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?CompletedHas ResultsBreast Cancer|Osteoporosis|Osteopenia|FractureDrug: Aromatase Inhibitorhttps://ClinicalTrials.gov/show/NCT00766532
137228137228Effect of Intraoperative Volume Optimization on Outcome After Intrabdominal SurgeryCompletedNo Results AvailableHemodynamic Instability|SurgeryOther: volume optimization|Other: standard volume administrationhttps://ClinicalTrials.gov/show/NCT00766519
137229137229An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic SurgeryTerminatedHas ResultsPain, PostoperativeDevice: Fentanyl IONSYS|Device: Morphine IV PCAhttps://ClinicalTrials.gov/show/NCT00766506
137230137230GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN)CompletedHas ResultsCarotid Artery StenosisDevice: GORE® Embolic Filterhttps://ClinicalTrials.gov/show/NCT00766493
137231137231Study of Tissue Samples in Predicting How Well Chemotherapy and Radiation Therapy Will Kill Cancer Cells in Patients With Squamous Cell Carcinoma of the EsophagusRecruitingNo Results AvailableEsophageal CancerDrug: cisplatin|Drug: fluorouracil|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00766480
137232137232A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant GliomasCompletedNo Results AvailableMalignant GliomaDrug: Armodafinil|Other: Placebohttps://ClinicalTrials.gov/show/NCT00766467
137233137233Studying Urine and Blood Samples in Women With Newly Diagnosed Breast CancerCompletedNo Results AvailableBreast CancerGenetic: DNA analysis|Genetic: mutation analysis|Genetic: polymorphism analysis|Other: laboratory biomarker analysis|Other: medical chart review|Other: questionnaire administration|Procedure: evaluation of cancer risk factorshttps://ClinicalTrials.gov/show/NCT00766454
137234137234Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During RamadanTerminatedNo Results AvailableDiabetes|HypoglycemiaDrug: Sitagliptin|Drug: sulphonylureahttps://ClinicalTrials.gov/show/NCT00766441
13723513723514729-D9831C00002- 1 Month Biopsy StudyCompletedHas ResultsChronic Obstructive Pulmonary DiseaseDrug: AZD1981|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00766415
137236137236An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)TerminatedNo Results AvailableSpondylitis, Ankylosing|PainDrug: Tramadol /acetaminophen|Drug: Diclofenachttps://ClinicalTrials.gov/show/NCT00766402
137237137237Retinal Nerve Fiber Layer Thickness Analysis With Cirrus HD OCT Versus Stratus Optical Coherence Tomography (OCT)RecruitingNo Results AvailableGlaucomahttps://ClinicalTrials.gov/show/NCT00766389
137238137238Safety and Efficacy Evaluation of Erbium TreatmentActive, not recruitingHas ResultsSkin AgingDevice: Erbium laserhttps://ClinicalTrials.gov/show/NCT00766376
137239137239Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's DiseaseCompletedHas ResultsAlzheimer's Disease|Central Nervous System DiseasesDrug: EVP-6124 (0.1 mg/day)|Drug: EVP-6124 (0.3 mg/day)|Drug: EVP-6124 (1.0 mg/day)|Drug: Comparator: Placebo|Drug: Donepezil|Drug: Rivastigminehttps://ClinicalTrials.gov/show/NCT00766363
137240137240Comparative Efficacy and Tolerability of Quetiapine XR and Amitriptyline in the Treatment of FibromyalgiaCompletedNo Results AvailableFibromyalgiaDrug: amitriptyline|Drug: quetiapinehttps://ClinicalTrials.gov/show/NCT00766350
137241137241Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular DegenerationTerminatedNo Results AvailableAge-Related Macular Degeneration|Choroidal NeovascularizationDrug: Sirolimus in combination with ranibizumab|Drug: Sirolimus in combination with ranibizumab|Drug: Placebo in combination with ranibizumabhttps://ClinicalTrials.gov/show/NCT00766337
137242137242PHA-739358 for Treatment of Hormone Refractory Prostate CancerCompletedNo Results AvailableMetastatic Hormone Refractory Prostate CancerDrug: PHA-739358|Drug: PHA-739358https://ClinicalTrials.gov/show/NCT00766324
137243137243Aerobic and Strengthening Exercise for Acute LeukemiaCompletedNo Results AvailableAcute Lymphoblastic LeukemiaOther: Gross Motor Function|Other: Knee extension strength|Other: Hand grip strength|Other: Flexibility|Other: Ankle range of motion|Other: Aerobic capacity|Other: Body composition and vital signshttps://ClinicalTrials.gov/show/NCT00766311
137244137244Skeletal Muscle Lipid and Insulin Resistance: Effects of Physical Activity and Weight LossActive, not recruitingNo Results AvailableType 2 Diabetes MellitusBehavioral: Exercise|Behavioral: Weight Loss|Behavioral: Exercise and weight losshttps://ClinicalTrials.gov/show/NCT00766298
137245137245High Dose Influenza in Immunosuppressed SubjectsWithdrawnNo Results AvailableInfluenzaBiological: Trivalent inactivated influenza vaccine|Biological: Trivalent Baculovirus-expressed Influenza HA vaccinehttps://ClinicalTrials.gov/show/NCT00766285
137246137246Lokomat Training Effects on MS Gait AbnormalitiesTerminatedNo Results AvailableMultiple SclerosisDevice: Lokomathttps://ClinicalTrials.gov/show/NCT00766272
137247137247Relationship of Staphylococcal Colonization to InfectionNot yet recruitingNo Results AvailableMRSA Infectionhttps://ClinicalTrials.gov/show/NCT00766259
137248137248Phase II Avastin Trial for Stage IIIB/IV NSCLCActive, not recruitingNo Results AvailableStage IIIB or IV Non-Small Cell Lung CancerDrug: bevacizumab|Drug: docetaxel|Drug: carboplatinhttps://ClinicalTrials.gov/show/NCT00766246
137249137249Optimal Application Dose of Surface HyperthermiaRecruitingNo Results AvailableTumorsOther: Hyperthermal treatmenthttps://ClinicalTrials.gov/show/NCT00766233
137250137250Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to LiverWithdrawnNo Results AvailableColon Cancer|Colorectal CancerDrug: SIR-spheres Agent Administration|Drug: Cetuximab|Drug: Irinotecanhttps://ClinicalTrials.gov/show/NCT00766220

* Görseller ve İçerik tekif hakkına sahip olabilir